Frequency Total Assets vs Net Invested Capital Analysis

KRRO Stock   52.31  1.69  3.34%   
Frequency Therapeutics financial indicator trend analysis is much more than just examining Frequency Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Frequency Therapeutics is a good investment. Please check the relationship between Frequency Therapeutics Total Assets and its Net Invested Capital accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.

Total Assets vs Net Invested Capital

Total Assets vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Frequency Therapeutics Total Assets account and Net Invested Capital. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Frequency Therapeutics' Total Assets and Net Invested Capital is 0.45. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Frequency Therapeutics, assuming nothing else is changed. The correlation between historical values of Frequency Therapeutics' Total Assets and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Frequency Therapeutics are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Total Assets i.e., Frequency Therapeutics' Total Assets and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.45
Relationship DirectionPositive 
Relationship StrengthWeak

Total Assets

Total assets refers to the total amount of Frequency Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Frequency Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.
Most indicators from Frequency Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Frequency Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.At this time, Frequency Therapeutics' Enterprise Value Over EBITDA is very stable compared to the past year. As of the 25th of November 2024, Enterprise Value Multiple is likely to grow to 0.75, while Tax Provision is likely to drop about 14.3 K.
 2023 2024 (projected)
Interest Expense106.2K106.1K
Depreciation And Amortization3.6M2.1M

Frequency Therapeutics fundamental ratios Correlations

-0.20.790.840.870.74-0.97-0.720.70.990.73-0.010.990.27-0.130.850.870.140.990.530.53-0.61-0.390.040.40.49
-0.2-0.31-0.14-0.07-0.340.30.44-0.3-0.11-0.38-0.1-0.150.01-0.28-0.33-0.21-0.35-0.160.20.070.560.250.16-0.65-0.26
0.79-0.310.50.80.96-0.76-0.960.950.740.960.170.730.32-0.10.980.920.060.740.090.02-0.73-0.84-0.40.60.83
0.84-0.140.50.80.4-0.91-0.490.40.880.390.160.88-0.02-0.360.640.73-0.050.880.710.87-0.22-0.24-0.060.10.25
0.87-0.070.80.80.77-0.9-0.710.770.910.750.320.860.05-0.550.870.96-0.320.870.60.49-0.32-0.6-0.270.10.59
0.74-0.340.960.40.77-0.71-0.920.980.691.00.270.670.18-0.130.940.890.00.670.15-0.08-0.7-0.78-0.330.520.78
-0.970.3-0.76-0.91-0.9-0.710.72-0.67-0.97-0.7-0.1-0.97-0.170.22-0.85-0.89-0.07-0.97-0.58-0.630.540.450.06-0.37-0.46
-0.720.44-0.96-0.49-0.71-0.920.72-0.95-0.66-0.94-0.33-0.65-0.130.07-0.96-0.87-0.09-0.66-0.02-0.010.70.820.53-0.64-0.86
0.7-0.30.950.40.770.98-0.67-0.950.660.990.390.620.07-0.190.940.89-0.060.630.13-0.08-0.63-0.83-0.470.480.82
0.99-0.110.740.880.910.69-0.97-0.660.660.670.050.990.2-0.240.810.870.040.990.630.61-0.5-0.360.040.270.44
0.73-0.380.960.390.751.0-0.7-0.940.990.670.280.650.17-0.10.940.880.020.660.11-0.1-0.72-0.8-0.370.560.79
-0.01-0.10.170.160.320.27-0.1-0.330.390.050.28-0.05-0.84-0.660.270.35-0.65-0.050.250.040.34-0.34-0.69-0.340.35
0.99-0.150.730.880.860.67-0.97-0.650.620.990.65-0.050.28-0.140.810.840.141.00.580.62-0.56-0.350.080.360.41
0.270.010.32-0.020.050.18-0.17-0.130.070.20.17-0.840.280.490.190.090.510.28-0.37-0.15-0.59-0.170.290.560.19
-0.13-0.28-0.1-0.36-0.55-0.130.220.07-0.19-0.24-0.1-0.66-0.140.49-0.19-0.410.95-0.14-0.51-0.37-0.570.240.470.67-0.24
0.85-0.330.980.640.870.94-0.85-0.960.940.810.940.270.810.19-0.190.970.010.810.230.19-0.66-0.8-0.410.530.79
0.87-0.210.920.730.960.89-0.89-0.870.890.870.880.350.840.09-0.410.97-0.20.840.420.34-0.48-0.74-0.390.310.74
0.14-0.350.06-0.05-0.320.0-0.07-0.09-0.060.040.02-0.650.140.510.950.01-0.20.14-0.31-0.11-0.680.180.480.76-0.18
0.99-0.160.740.880.870.67-0.97-0.660.630.990.66-0.051.00.28-0.140.810.840.140.580.61-0.56-0.350.070.360.42
0.530.20.090.710.60.15-0.58-0.020.130.630.110.250.58-0.37-0.510.230.42-0.310.580.780.180.130.29-0.43-0.24
0.530.070.020.870.49-0.08-0.63-0.01-0.080.61-0.10.040.62-0.15-0.370.190.34-0.110.610.780.160.190.17-0.24-0.18
-0.610.56-0.73-0.22-0.32-0.70.540.7-0.63-0.5-0.720.34-0.56-0.59-0.57-0.66-0.48-0.68-0.560.180.160.44-0.09-0.93-0.46
-0.390.25-0.84-0.24-0.6-0.780.450.82-0.83-0.36-0.8-0.34-0.35-0.170.24-0.8-0.740.18-0.350.130.190.440.71-0.42-0.8
0.040.16-0.4-0.06-0.27-0.330.060.53-0.470.04-0.37-0.690.080.290.47-0.41-0.390.480.070.290.17-0.090.71-0.06-0.72
0.4-0.650.60.10.10.52-0.37-0.640.480.270.56-0.340.360.560.670.530.310.760.36-0.43-0.24-0.93-0.42-0.060.45
0.49-0.260.830.250.590.78-0.46-0.860.820.440.790.350.410.19-0.240.790.74-0.180.42-0.24-0.18-0.46-0.8-0.720.45
Click cells to compare fundamentals

Frequency Therapeutics Account Relationship Matchups

Frequency Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets223.2M264.7M127.6M73.7M221.7M153.3M
Other Current Liab3.4M6.7M4.2M3.2M10.2M10.7M
Total Current Liabilities52.8M26.6M4.9M8.7M19.5M18.6M
Total Stockholder Equity167.4M192.5M(42.2M)(99.0M)169.9M178.4M
Property Plant And Equipment Net1.8M37.8M7.1M11.9M42.8M45.0M
Net Debt(200.2M)(174.3M)(37.9M)(33.2M)(132.9M)(126.3M)
Retained Earnings(68.9M)(95.4M)(43.8M)(101.8M)(183.0M)(173.9M)
Accounts Payable1.2M5.5M789K2.6M7.3M7.6M
Cash200.2M220.3M83.5M36.3M166.2M120.5M
Non Current Assets Total1.9M39.7M7.8M16.7M48.9M51.4M
Non Currrent Assets Other101.0K(1.0)(12.8M)228K2.7M2.8M
Cash And Short Term Investments217.4M220.3M118.5M55.2M166.2M131.6M
Common Stock Shares Outstanding616.9K645.1K4.4M255.2K1.5M1.4M
Liabilities And Stockholders Equity223.2M264.7M127.6M73.7M221.7M153.3M
Non Current Liabilities Total3.1M45.6M164.8M164.1M32.3M30.7M
Other Current Assets3.2M4.4M1.2M1.8M6.6M6.9M
Other Stockholder Equity236.2M287.8M1.6M2.8M352.9M370.6M
Total Liab55.9M72.2M169.8M172.8M51.8M49.2M
Total Current Assets221.4M225.1M119.8M57.1M172.7M134.7M
Common Stock14K31K34K5K8K7.2K

Pair Trading with Frequency Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Frequency Stock

  0.67MTEM Molecular TemplatesPairCorr
  0.58ME 23Andme HoldingPairCorr
  0.57TPST Tempest TherapeuticsPairCorr
  0.53MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.5A Agilent Technologies Earnings Call TodayPairCorr
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Frequency Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Frequency Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Frequency Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Frequency Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.42)
Return On Assets
(0.35)
Return On Equity
(0.75)
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.